spot_img
Friday, August 12, 2022
More
    HomeHealthIndustry-funded studies on cost-efficacy often favor pricier drugs

    Industry-funded studies on cost-efficacy often favor pricier drugs

    -



    In response to rising costs for medicines, private and non-private payers more and more depend on assessments of cost-effectiveness to justify protection. However a brand new examination finds that such research sponsored by drug corporations had been usually biased in favor of setting greater costs for his or her medicines.

    Particularly, one-third of the cost-effectiveness analyses that had been carried out by drugmakers reached extra favorable conclusions than independently carried out analyses. And industry-sponsored analyses had been twice as more likely to report {that a} drugs was price efficient when counting on a generally used metric to gauge the worth of a drugs, in response to the examine printed in The BMJ.

    Unlock this text by subscribing to STAT+ and luxuriate in your first 30 days free!

    GET STARTED





    Source link

    Related articles

    Stay Connected

    0FansLike
    0FollowersFollow
    3,433FollowersFollow
    0SubscribersSubscribe
    spot_img

    Latest posts